Longitudinal comparison of bone mass and bone quality before and after treatment with eldecalcitol in the patients with Turner syndrome and low bone mass even after HRT

Longitudinal comparison of bone mass and bone quality before and after treatment with eldecalcitol in the patients with Turner syndrome and low bone mass even after HRT - Longitudinal comparison of bone mass and bone quality before and after treatment with eldecalcitol in the patients with Turner syndrome and low bone mass even after HRT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027959

Enrollment

Registered

2017-06-28

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Turner syndrome

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) patients with Turner syndrome and low bone mass even after HRT 2) Patients enable to informed consent in document

Exclusion criteria

Exclusion criteria: 1) Patients with untreated mental disorder 2) Patients who judged as inappropriate for this study by the attending physician

Design outcomes

Primary

Measure	Time frame
urinary pentosidine	—

Secondary

Measure	Time frame
bone mineral density (BMD) urinary cross-linked N-telopeptides of type I collagen (uNTX) serum intact procollagen type I N-terminal propeptide (intact-P1NP)	—

Countries

Japan

Contacts

Public ContactTaku Tsuburai

Yokohama City University Medical Center Gynecology

tsubutsububuu@yahoo.co.jp045-261-5656

Outcome results